Application

17101961 · USE OF FLIBANSERIN IN THE TREATMENT OF OBESITY

Filed 2020-11-23 · Abandoned The official file ↗ · Art unit 1629 · Examiner Kevin E Weddington Easy · CPC A61K 31/496 · Sprout Pharmaceuticals, Inc. · WOMBLE BOND DICKINSON (US) LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

21.9 mo

to disposition 37.5 mo

Statutes raised

102 112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.